About Us

David Hail

David Hail

CEO

Over 30 years’ experience within and consulting to the pharmaceutical, healthcare and molecular imaging industries at Senior Executive and Board level.

Mark Rosser

Mark Rosser

PhD

COO

Mark has been working on the development of radiopharmaceutical imaging products for the management of chronic disease for 25 years, with experiences covering manufacturing and supply through clinical development and regulatory submissions.

Paul Cload

Paul Cload

PhD

CMO

Over 30 years’ experience in the pharmaceutical, medical device and diagnostics industries having held senior, global positions in clinical development and strategic/tactical marketing.

Pat Butler

Pat Butler

Board Observer and Advisor

Pat is a director of Hikma Pharmaceuticals, Chairman of Aldermore Bank, was formerly a Senior Director at McKinsey & Co., and is a qualified chartered accountant. He is also a Governor of the British Film Institute and a trustee of the Resolution Foundation.

Roger Humm

Roger Humm

FCA

CFO

Roger is a chartered accountant and experienced commercial and finance director with extensive knowledge of high growth technology companies both in the public and private markets, including diagnostics, medical devices and imaging amongst other sectors.

Jon Barnett

Jon Barnett

PhD

Head of CMC & Supply

Over 20 years’ experience on radiopharmaceutical and biopharmaceutical product development and commercial supply, Jon has extensive experience of leading global functional and cross-functional project / operational teams to deliver new products and life cycle improvements.

Druin Burch

Druin Burch

FRCP

CSO

Consultant Physician at the Oxford University Hospitals NHS Trust, with three decades experience as a clinician, scientist and writer in the field of developing and testing medical technology.

Julie Davis

Julie Davis

Quality Management

A career spent in life science and radiopharmaceutical drug discovery, most recently consulting with biotech start-ups including leading the development and implementation of operational processes and quality systems.

Colin Esbrand

Colin Esbrand

PhD

Head of Development (HGC)

Fourteen years’ biomedical engineering programme and project management experience - leading cross functional global teams in the development of medical devices.

Sarah Prideaux-Turner

Sarah Prideaux-Turner

Financial Controller

Sarah has over 25 years experience at both Director and Controller level in building and running successful finance departments primarily in high-tech, high-growth SME companies. Over the past decade she has worked in predominantly bio-tech and medical device R&D companies.